Vertex Pharma Says VX-135 Holds Promise For Hepatitis C
4/23/2013 9:52:00 AM - RTT News
Catalyst Deserves The Attention
4/23/2013 4:43:00 AM - Seeking Alpha
FDA Approves Novartis' Simbrinza - Analyst Blog
4/22/2013 6:12:49 PM - Zacks.com
Merck In-Licenses from Xenon - Analyst Blog
4/22/2013 6:11:06 PM - Zacks.com
Market Close Report: NASDAQ Composite index closes at 3,233.55 up 27.49 points
4/22/2013 4:45:13 PM - NASDAQ.com News
Today's Market News To Trade On: 5 Stocks Moving On News
4/22/2013 8:30:00 AM - Seeking Alpha
Biotech Stocks Get A Turbo Boost From Vertex
4/20/2013 9:33:00 AM - Seeking Alpha
Market Close Report: NASDAQ Composite index closes at 3,206.06 up 39.70 points
4/19/2013 4:45:16 PM - NASDAQ.com News
PSTI Plans to Start Phase I Study - Analyst Blog
4/19/2013 4:11:14 PM - Zacks.com
BMY, Santaris Pharma Team Up - Analyst Blog
4/19/2013 4:10:30 PM - Zacks.com
Vertex CF Candidate Impresses - Analyst Blog
4/19/2013 3:40:01 PM - Zacks.com
Mid-Day Market Update: Celanese Jumps On Upbeat Results, Rambus Declines
4/19/2013 1:16:28 PM - Benzinga
Mid-Morning Market Update: Markets Mixed, General Electric Q1 Profit Surges 16%
4/19/2013 10:02:53 AM - Benzinga
Pre-Market Most Active for Apr 19, 2013 : DELL, GE, VOD, QQQ, TOT, MSFT, BAC, VRTX, SAP, NOK, BIOS, DEO
4/19/2013 8:39:55 AM - NASDAQ.com News
U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
4/19/2013 6:45:00 AM - Dow Jones Business News
Vertex Stock Up 51% On Positive Phase-2 Results For Cystic Fibrosis Drug
4/18/2013 8:28:00 PM - RTT News
UPDATE: Vertex Pharmaceuticals Shares Surge on Cystic Fibrosis Data
4/18/2013 7:35:00 PM - Dow Jones Business News
Vertex Pharma Cystic Fibrosis Drug Promising - Quick Facts
4/18/2013 6:46:00 PM - RTT News
After Hours Most Active for Apr 18, 2013 : QQQ, JCP, MSFT, VRTX, HTA, BAC, AMD, IBM, VMED, MDLZ, NOK, ORCL
4/18/2013 4:44:58 PM - NASDAQ.com News
Achillion's HCV Candidates Progress - Analyst Blog
4/17/2013 5:12:52 PM - Zacks.com
Actelion Beats Earnings, Sales Rise - Analyst Blog
4/16/2013 7:08:40 PM - Zacks.com
Roche Teams Up with Ascletis - Analyst Blog
4/15/2013 6:10:01 PM - Zacks.com
Vertex-Bristol-Myers Collaborate for HCV - Analyst Blog
4/8/2013 10:50:01 AM - Zacks.com
Vertex Signs Deal With Bristol-Myers for Hepatitis C Treatment Studies
4/5/2013 8:43:00 AM - Dow Jones Business News
Vertex Agrees With Bristol-Myers Squibb For Phase 2 All-Oral Studies Of VX-135
4/5/2013 8:30:00 AM - RTT News
